Simultaneously, Figure 3A and 3B showed that ORI intervention can increase perivascular cell coverage of colon cancer, and CD31+/α-SMA+ double immunofluorescent labeling was dramatically increased from days 5 to 10. This evidence concerns the gene ACTA1 and malignant colon neoplasm.